The ENDORISK team looks back on a valuable evening with gynecologists from 11 of the 15 participating hospitals. During this event, the ENDORISK team provided an introduction to the ENDORISK Clinical Implementation Study (ENDORISK-I study) and worked on applying ENDORISK in a (practice) consultation.
An interesting discussion emerged about how to communicate the risk score to the patient and what information doctors need to effectively use these personalized risks for lymph node metastasis in their conversations with patients.
We received a lot of valuable feedback, which will help us further develop our user interface (www.endorisk.eu) and materials to better meet your needs.

Comentarios